Vespula pensylvanica isolate Volc-1 chromosome 12, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025347.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial ribonuclease P catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial folate transporter/carrier
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 60% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122633348, transcript variant X5
uncharacterized LOC122633348, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122633348, transcript variant X1
uncharacterized LOC122633348, transcript variant X2
uncharacterized LOC122633348, transcript variant X3
uncharacterized protein LOC122633348 isoform X1
uncharacterized protein LOC122633348 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122633290, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122633290, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122633290, transcript variant X1
uncharacterized protein LOC122633290 isoform X1
uncharacterized LOC122633290, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122633290 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acetylcholine receptor subunit alpha-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 235 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like 2, transcript variant X2
acetylcholine receptor subunit alpha-like 2, transcript variant X1
acetylcholine receptor subunit alpha-like 2 isoform X1
acetylcholine receptor subunit alpha-like 2 isoform X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
arylalkylamine N-acetyltransferase 1-like, transcript variant X1
arylalkylamine N-acetyltransferase 1-like
arylalkylamine N-acetyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger protein 622, transcript variant X1
zinc finger protein 622, transcript variant X2
uncharacterized LOC122633615, transcript variant X1
uncharacterized protein LOC122633615 isoform X1
uncharacterized LOC122633615, transcript variant X2
uncharacterized protein LOC122633615 isoform X2
eukaryotic translation initiation factor 5
kinesin light chain, transcript variant X5
kinesin light chain, transcript variant X4
kinesin light chain, transcript variant X2
kinesin light chain, transcript variant X3
kinesin light chain, transcript variant X1
kinesin light chain, transcript variant X8
kinesin light chain, transcript variant X12
kinesin light chain, transcript variant X11
kinesin light chain, transcript variant X13
kinesin light chain, transcript variant X10
kinesin light chain, transcript variant X6
kinesin light chain, transcript variant X9
kinesin light chain, transcript variant X7
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X2
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X1
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X3
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X1
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X2
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X3
dynein axonemal assembly factor 10, transcript variant X2
dynein axonemal assembly factor 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
adenosine 3'-phospho 5'-phosphosulfate transporter 1
uncharacterized aarF domain-containing protein kinase 2-like
ecdysone 20-monooxygenase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X10
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X7
ecdysone 20-monooxygenase, transcript variant X4
ecdysone 20-monooxygenase, transcript variant X6
ecdysone 20-monooxygenase, transcript variant X3
ecdysone 20-monooxygenase, transcript variant X2
ecdysone 20-monooxygenase, transcript variant X5
ecdysone 20-monooxygenase, transcript variant X9
cyclin-dependent kinase 8, transcript variant X2
cyclin-dependent kinase 8, transcript variant X1
cyclin-dependent kinase 8, transcript variant X3
uridine phosphorylase 1, transcript variant X3
uridine phosphorylase 1, transcript variant X2
uridine phosphorylase 1, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC122633624, transcript variant X1
uncharacterized LOC122633624, transcript variant X2
uncharacterized protein LOC122633624 isoform X1
uncharacterized protein LOC122633624 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
MAGUK p55 subfamily member 7, transcript variant X3
MAGUK p55 subfamily member 7, transcript variant X4
MAGUK p55 subfamily member 7, transcript variant X1
MAGUK p55 subfamily member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC122633461, transcript variant X4
uncharacterized LOC122633461, transcript variant X5
uncharacterized LOC122633461, transcript variant X2
uncharacterized LOC122633461, transcript variant X1
uncharacterized LOC122633461, transcript variant X3
inorganic pyrophosphatase, transcript variant X2
inorganic pyrophosphatase, transcript variant X1
serine/threonine-protein kinase Warts, transcript variant X1
serine/threonine-protein kinase Warts, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X10
heterogeneous nuclear ribonucleoprotein R, transcript variant X8
heterogeneous nuclear ribonucleoprotein R, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X5
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X9
heterogeneous nuclear ribonucleoprotein R, transcript variant X11
heterogeneous nuclear ribonucleoprotein R, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X17
heterogeneous nuclear ribonucleoprotein R, transcript variant X13
heterogeneous nuclear ribonucleoprotein R, transcript variant X14
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
heterogeneous nuclear ribonucleoprotein R, transcript variant X6
heterogeneous nuclear ribonucleoprotein R, transcript variant X7
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X3
heterogeneous nuclear ribonucleoprotein R isoform X4
heterogeneous nuclear ribonucleoprotein R isoform X5
heterogeneous nuclear ribonucleoprotein R isoform X6
heterogeneous nuclear ribonucleoprotein R isoform X10
heterogeneous nuclear ribonucleoprotein R isoform X2
heterogeneous nuclear ribonucleoprotein R isoform X7
heterogeneous nuclear ribonucleoprotein R isoform X9
heterogeneous nuclear ribonucleoprotein R isoform X8
tolloid-like protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tolloid-like protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tolloid-like protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tolloid-like protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
tolloid-like protein 1, transcript variant X1
tolloid-like protein 1, transcript variant X5
tolloid-like protein 1, transcript variant X6
tolloid-like protein 1, transcript variant X3
tolloid-like protein 1, transcript variant X2
tolloid-like protein 1, transcript variant X4
uncharacterized LOC122633603, transcript variant X1
uncharacterized LOC122633603, transcript variant X2
uncharacterized LOC122633603, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC122633603 isoform X1
uncharacterized protein LOC122633603 isoform X2
uncharacterized protein LOC122633603 isoform X3
protein artichoke, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein artichoke, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vacuolar protein sorting-associated protein 16 homolog, transcript variant X2
vacuolar protein sorting-associated protein 16 homolog, transcript variant X1
vacuolar protein sorting-associated protein 16 homolog isoform X1
vacuolar protein sorting-associated protein 16 homolog isoform X2
tyrosine-protein kinase Fer, transcript variant X1
tyrosine-protein kinase Fer, transcript variant X2
tyrosine-protein kinase Fer, transcript variant X3
tyrosine-protein kinase Fer, transcript variant X4
translation initiation factor eIF-2B subunit alpha, transcript variant X1
translation initiation factor eIF-2B subunit alpha, transcript variant X2
translation initiation factor eIF-2B subunit alpha isoform X1
translation initiation factor eIF-2B subunit alpha isoform X2
pescadillo homolog, transcript variant X1
pescadillo homolog, transcript variant X2
uncharacterized LOC122633439, transcript variant X1
uncharacterized LOC122633439, transcript variant X2
uncharacterized protein LOC122633439 isoform X1
uncharacterized protein LOC122633439 isoform X2
spectrin alpha chain, transcript variant X2
spectrin alpha chain, transcript variant X1
ecdysone-induced protein 74EF, transcript variant X1
ecdysone-induced protein 74EF, transcript variant X2
ecdysone-induced protein 74EF, transcript variant X3
ecdysone-induced protein 74EF isoform X2
ecdysone-induced protein 74EF isoform X1
ecdysone-induced protein 74EF isoform X3
uncharacterized LOC122633346, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122633346, transcript variant X2
U7 snRNA-associated Sm-like protein LSm11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
anaphase-promoting complex subunit 15-like, transcript variant X2
anaphase-promoting complex subunit 15-like, transcript variant X1
anaphase-promoting complex subunit 15-like isoform X2
anaphase-promoting complex subunit 15-like isoform X1
ras-related protein Rab-9A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ras-related protein Rab-9A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
high affinity copper uptake protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
ras-related protein Rab-9A, transcript variant X4
ras-related protein Rab-9A, transcript variant X5
ras-related protein Rab-9A, transcript variant X3
ras-related protein Rab-9A, transcript variant X2
mitochondrial mRNA pseudouridine synthase Trub2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
14 kDa phosphohistidine phosphatase-like
phosrestin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosrestin-2-like, transcript variant X3
phosrestin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC122633224 isoform X2
nuclear pore complex protein Nup214, transcript variant X1
nuclear pore complex protein Nup214, transcript variant X2
nuclear pore complex protein Nup214 isoform X1
nuclear pore complex protein Nup214 isoform X2
tRNA-uridine aminocarboxypropyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 3, transcript variant X5
long-chain-fatty-acid--CoA ligase 3, transcript variant X4
long-chain-fatty-acid--CoA ligase 3, transcript variant X2
long-chain-fatty-acid--CoA ligase 3, transcript variant X3
long-chain-fatty-acid--CoA ligase 3, transcript variant X6
long-chain-fatty-acid--CoA ligase 3, transcript variant X7
long-chain-fatty-acid--CoA ligase 3, transcript variant X1
long-chain-fatty-acid--CoA ligase 3 isoform X1
long-chain-fatty-acid--CoA ligase 3 isoform X2
long-chain-fatty-acid--CoA ligase 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122633297, transcript variant X2
uncharacterized LOC122633297, transcript variant X1
breast cancer type 1 susceptibility protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
putative uncharacterized protein DDB_G0282133
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
putative mediator of RNA polymerase II transcription subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
inaD-like protein, transcript variant X2
inaD-like protein, transcript variant X4
inaD-like protein, transcript variant X1
inaD-like protein, transcript variant X3
inaD-like protein, transcript variant X5
inaD-like protein, transcript variant X6
inaD-like protein, transcript variant X7
uncharacterized protein LOC122633230 isoform X1
uncharacterized protein LOC122633230 isoform X2
uncharacterized LOC122633233, transcript variant X1
uncharacterized LOC122633233, transcript variant X2
uncharacterized LOC122633233, transcript variant X3
uncharacterized LOC122633233, transcript variant X4
uncharacterized protein LOC122633233 isoform X1
uncharacterized protein LOC122633233 isoform X2
uncharacterized protein LOC122633233 isoform X3
uncharacterized protein LOC122633233 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 3 isoform X2
uncharacterized protein LOC122633242 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
inositol-pentakisphosphate 2-kinase, transcript variant X3
inositol-pentakisphosphate 2-kinase, transcript variant X2
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase isoform X1
inositol-pentakisphosphate 2-kinase isoform X2
inositol-pentakisphosphate 2-kinase isoform X3
protein BTG2-like, transcript variant X1
protein BTG2-like, transcript variant X3
protein BTG2-like, transcript variant X2
sterol regulatory element-binding protein 1
amidophosphoribosyltransferase-like, transcript variant X4
amidophosphoribosyltransferase-like, transcript variant X5
amidophosphoribosyltransferase-like, transcript variant X3
amidophosphoribosyltransferase-like, transcript variant X6
amidophosphoribosyltransferase-like, transcript variant X2
amidophosphoribosyltransferase-like, transcript variant X1
multifunctional protein ADE2, transcript variant X2
amidophosphoribosyltransferase-like isoform X2
amidophosphoribosyltransferase-like isoform X1
amidophosphoribosyltransferase-like isoform X3
multifunctional protein ADE2, transcript variant X1
xaa-Pro aminopeptidase 3, transcript variant X2
xaa-Pro aminopeptidase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
polypyrimidine tract-binding protein 1, transcript variant X13
polypyrimidine tract-binding protein 1, transcript variant X8
polypyrimidine tract-binding protein 1, transcript variant X10
polypyrimidine tract-binding protein 1, transcript variant X7
polypyrimidine tract-binding protein 1, transcript variant X6
polypyrimidine tract-binding protein 1, transcript variant X4
polypyrimidine tract-binding protein 1, transcript variant X5
polypyrimidine tract-binding protein 1, transcript variant X12
polypyrimidine tract-binding protein 1, transcript variant X11
polypyrimidine tract-binding protein 1, transcript variant X3
polypyrimidine tract-binding protein 1, transcript variant X2
polypyrimidine tract-binding protein 1, transcript variant X1
polypyrimidine tract-binding protein 1, transcript variant X9
polypyrimidine tract-binding protein 3 isoform X11
polypyrimidine tract-binding protein 1 isoform X7
polypyrimidine tract-binding protein 3 isoform X9
polypyrimidine tract-binding protein 1 isoform X6
polypyrimidine tract-binding protein 1 isoform X5
polypyrimidine tract-binding protein 1 isoform X4
polypyrimidine tract-binding protein 1 isoform X3
polypyrimidine tract-binding protein 1 isoform X2
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X10
polypyrimidine tract-binding protein 3 isoform X8
esterase FE4-like, transcript variant X3
esterase FE4-like, transcript variant X2
esterase FE4-like, transcript variant X4
esterase FE4-like, transcript variant X1
quinone oxidoreductase-like protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122633580, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC122633580, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
pancreatic lipase-related protein 2-like
pancreatic triacylglycerol lipase-like, transcript variant X3
pancreatic triacylglycerol lipase-like, transcript variant X2
pancreatic triacylglycerol lipase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like, transcript variant X1
pancreatic triacylglycerol lipase-like, transcript variant X8
pancreatic triacylglycerol lipase-like, transcript variant X7
pancreatic triacylglycerol lipase-like, transcript variant X9
pancreatic triacylglycerol lipase-like isoform X1
pancreatic triacylglycerol lipase-like isoform X4
pancreatic triacylglycerol lipase-like isoform X3
pancreatic triacylglycerol lipase-like isoform X5
pancreatic triacylglycerol lipase-like, transcript variant X6
pancreatic triacylglycerol lipase-like isoform X2
uncharacterized protein DDB_G0283357, transcript variant X5
uncharacterized protein DDB_G0283357, transcript variant X4
uncharacterized protein DDB_G0283357, transcript variant X3
uncharacterized protein DDB_G0283357, transcript variant X2
uncharacterized protein DDB_G0283357, transcript variant X1
uncharacterized protein DDB_G0283357 isoform X5
uncharacterized protein DDB_G0283357 isoform X4
uncharacterized protein DDB_G0283357 isoform X3
uncharacterized protein DDB_G0283357 isoform X2
uncharacterized protein DDB_G0283357 isoform X1
ras-related protein Rab-18-B, transcript variant X2
ras-related protein Rab-18-B, transcript variant X1
protein RCC2 homolog, transcript variant X3
protein RCC2 homolog, transcript variant X2
protein RCC2 homolog, transcript variant X1
mpv17-like protein 2, transcript variant X3
mpv17-like protein 2, transcript variant X2
mpv17-like protein 2, transcript variant X1
translation initiation factor eIF-2B subunit gamma
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit trm6
long-chain fatty acid transport protein 4, transcript variant X6
long-chain fatty acid transport protein 4, transcript variant X2
long-chain fatty acid transport protein 4, transcript variant X1
long-chain fatty acid transport protein 4 isoform X1
long-chain fatty acid transport protein 4, transcript variant X5
long-chain fatty acid transport protein 4, transcript variant X3
long-chain fatty acid transport protein 4, transcript variant X4
long-chain fatty acid transport protein 4 isoform X2
long-chain fatty acid transport protein 4 isoform X3
long-chain fatty acid transport protein 4-like
uncharacterized LOC122633438, transcript variant X1
uncharacterized LOC122633438, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
GATA zinc finger domain-containing protein 8-like
solute carrier family 22 member 5-like, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X3
solute carrier family 22 member 5-like isoform X2
solute carrier family 22 member 5-like, transcript variant X1
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like, transcript variant X4
solute carrier family 22 member 5-like isoform X3
probable cationic amino acid transporter, transcript variant X1
probable cationic amino acid transporter, transcript variant X2
probable cationic amino acid transporter, transcript variant X5
probable cationic amino acid transporter, transcript variant X3
probable cationic amino acid transporter, transcript variant X4
probable cationic amino acid transporter, transcript variant X6
probable cationic amino acid transporter, transcript variant X7
probable cationic amino acid transporter, transcript variant X8
probable cationic amino acid transporter
protein obstructor-E-like, transcript variant X2
protein obstructor-E-like, transcript variant X1
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein purity of essence, transcript variant X2
protein purity of essence, transcript variant X3
protein purity of essence, transcript variant X1
protein purity of essence, transcript variant X4
golgin subfamily A member 1, transcript variant X1
golgin subfamily A member 1, transcript variant X2
receptor-type tyrosine-protein phosphatase mu
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
H/ACA ribonucleoprotein complex non-core subunit NAF1
riboflavin kinase, transcript variant X2
riboflavin kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
DNA primase large subunit-like, transcript variant X4
DNA primase large subunit-like, transcript variant X3
DNA primase large subunit-like, transcript variant X1
DNA primase large subunit-like, transcript variant X2
DNA primase large subunit-like isoform X2
DNA primase large subunit-like isoform X1
DNA primase large subunit-like isoform X4
DNA primase large subunit-like isoform X3
nuclear RNA export factor 1-like, transcript variant X1
nuclear RNA export factor 1-like, transcript variant X2
nuclear RNA export factor 1-like isoform X1
nuclear RNA export factor 1-like isoform X2
uncharacterized protein C16C10.8, transcript variant X2
uncharacterized protein C16C10.8, transcript variant X1
cell growth-regulating nucleolar protein isoform X1
uncharacterized protein C16C10.8 isoform X2
GTP-binding protein 2, transcript variant X3
GTP-binding protein 2, transcript variant X2
GTP-binding protein 2, transcript variant X1
neural/ectodermal development factor IMP-L2, transcript variant X1
neural/ectodermal development factor IMP-L2, transcript variant X2
neural/ectodermal development factor IMP-L2 isoform X1
neural/ectodermal development factor IMP-L2 isoform X2
defective pharyngeal development protein 4-like, transcript variant X2
defective pharyngeal development protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
defective pharyngeal development protein 4-like isoform X1
uncharacterized protein LOC122633338 isoform X2
polyadenylate-binding protein 2-like, transcript variant X2
polyadenylate-binding protein 2-like, transcript variant X1
protein zyg-11 homolog B-like, transcript variant X2
protein zyg-11 homolog B-like, transcript variant X1
protein zyg-11 homolog B-like, transcript variant X4
protein zyg-11 homolog B-like, transcript variant X3
protein zyg-11 homolog B-like isoform X2
protein zyg-11 homolog B-like isoform X1
PP2C-like domain-containing protein CG9801, transcript variant X2
PP2C-like domain-containing protein CG9801, transcript variant X1
PP2C-like domain-containing protein CG9801
protein PF14_0175, transcript variant X1
protein PF14_0175, transcript variant X2
uncharacterized protein LOC122633473 isoform X1
putative uncharacterized protein DDB_G0277255
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X3
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X4
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X8
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X7
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X6
solute carrier family 2, facilitated glucose transporter member 1-like isoform X3
solute carrier family 2, facilitated glucose transporter member 1-like isoform X1
solute carrier family 2, facilitated glucose transporter member 1-like isoform X2
solute carrier family 2, facilitated glucose transporter member 1-like isoform X4
solute carrier family 2, facilitated glucose transporter member 1-like isoform X6
solute carrier family 2, facilitated glucose transporter member 1-like isoform X5
solute carrier family 2, facilitated glucose transporter member 1-like isoform X7
GTP-binding protein 10 homolog, transcript variant X2
GTP-binding protein 10 homolog, transcript variant X1
GTP-binding protein 10 homolog isoform X1
GTP-binding protein 10 homolog isoform X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X2
RNA-binding protein 33-like, transcript variant X1
RNA-binding protein 33-like, transcript variant X2
DEAD-box helicase Dbp80, transcript variant X1
DEAD-box helicase Dbp80, transcript variant X2
10 kDa heat shock protein, mitochondrial
39S ribosomal protein L20, mitochondrial
INO80 complex subunit C, transcript variant X1
INO80 complex subunit C, transcript variant X2
prostaglandin E synthase 3, transcript variant X1
prostaglandin E synthase 3, transcript variant X2
uncharacterized LOC122633641, transcript variant X3
uncharacterized LOC122633641, transcript variant X1
uncharacterized LOC122633641, transcript variant X2
exosome component 10, transcript variant X2
exosome component 10, transcript variant X1
popeye domain-containing protein 3-like, transcript variant X2
popeye domain-containing protein 3-like, transcript variant X1
popeye domain-containing protein 3-like isoform X2
popeye domain-containing protein 3-like isoform X1
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase receptor Ret
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like isoform X2
synaptic vesicle glycoprotein 2B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122633272, transcript variant X4
uncharacterized LOC122633272, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122633272, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122633272, transcript variant X3
outer mitochondrial transmembrane helix translocase
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X8
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X1
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X6
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X7
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X5
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X4
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X5
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X6
N6-adenosine-methyltransferase non-catalytic subunit
protein bicaudal C homolog 1-A, transcript variant X3
protein bicaudal C homolog 1-A, transcript variant X2
protein bicaudal C homolog 1-A, transcript variant X1
protein bicaudal C homolog 1-A, transcript variant X4
protein bicaudal C homolog 1-A, transcript variant X5
protein bicaudal C homolog 1-A isoform X3
peroxisome biogenesis factor 2, transcript variant X3
peroxisome biogenesis factor 2, transcript variant X4
peroxisome biogenesis factor 2, transcript variant X2
peroxisome biogenesis factor 2, transcript variant X1
peroxisome biogenesis factor 2 isoform X1
peroxisome biogenesis factor 2 isoform X2
stress-activated protein kinase JNK, transcript variant X1
stress-activated protein kinase JNK, transcript variant X4
stress-activated protein kinase JNK, transcript variant X10
stress-activated protein kinase JNK, transcript variant X3
stress-activated protein kinase JNK, transcript variant X9
stress-activated protein kinase JNK, transcript variant X11
stress-activated protein kinase JNK, transcript variant X6
stress-activated protein kinase JNK, transcript variant X7
stress-activated protein kinase JNK, transcript variant X2
stress-activated protein kinase JNK, transcript variant X8
stress-activated protein kinase JNK, transcript variant X5
stress-activated protein kinase JNK isoform X1
stress-activated protein kinase JNK, transcript variant X12
stress-activated protein kinase JNK isoform X2
DNA-directed RNA polymerase II subunit RPB11
CAP-Gly domain-containing linker protein 2 isoform X7
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
myeloid differentiation primary response protein MyD88, transcript variant X2
myeloid differentiation primary response protein MyD88, transcript variant X1
myeloid differentiation primary response protein MyD88
NAD(+) hydrolase sarm1, transcript variant X6
NAD(+) hydrolase sarm1, transcript variant X10
NAD(+) hydrolase sarm1, transcript variant X5
NAD(+) hydrolase sarm1, transcript variant X7
NAD(+) hydrolase sarm1, transcript variant X4
NAD(+) hydrolase sarm1, transcript variant X3
NAD(+) hydrolase sarm1, transcript variant X2
NAD(+) hydrolase sarm1, transcript variant X9
NAD(+) hydrolase sarm1, transcript variant X1
NAD(+) hydrolase sarm1, transcript variant X11
NAD(+) hydrolase sarm1, transcript variant X8
NAD(+) hydrolase sarm1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase NLK, transcript variant X2
serine/threonine-protein kinase NLK, transcript variant X1
serine/threonine-protein kinase NLK isoform X1
serine/threonine-protein kinase NLK, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
serine/threonine-protein kinase NLK isoform X2
ubiquitin-protein ligase E3B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin-protein ligase E3B, transcript variant X5
ubiquitin-protein ligase E3B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin-protein ligase E3B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
ubiquitin-protein ligase E3B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF185-like, transcript variant X1
E3 ubiquitin-protein ligase RNF185-like, transcript variant X4
E3 ubiquitin-protein ligase RNF185-like, transcript variant X5
E3 ubiquitin-protein ligase RNF185-like, transcript variant X3
E3 ubiquitin-protein ligase RNF185-like, transcript variant X2
E3 ubiquitin-protein ligase RNF185-like, transcript variant X7
E3 ubiquitin-protein ligase RNF185-like, transcript variant X6
dynein axonemal intermediate chain 4-like
heat shock protein DDB_G0288861, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
heat shock protein DDB_G0288861, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
heat shock protein DDB_G0288861, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
heat shock protein DDB_G0288861, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
heat shock protein DDB_G0288861, transcript variant X6
heat shock protein DDB_G0288861, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heat shock protein DDB_G0288861 isoform X1
heat shock protein DDB_G0288861, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heat shock protein DDB_G0288861 isoform X2
heat shock protein DDB_G0288861, transcript variant X8
uncharacterized protein LOC122633283 isoform X3
transmembrane protein 138-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 138-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 138-like isoform X1
transmembrane protein 138-like isoform X2
uncharacterized LOC122633364, transcript variant X1
uncharacterized LOC122633364, transcript variant X2
uncharacterized LOC122633364, transcript variant X3
uncharacterized LOC122633364, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122633364 isoform X1
uncharacterized protein LOC122633364 isoform X2
uncharacterized protein LOC122633364 isoform X4
uncharacterized protein LOC122633364 isoform X3
nose resistant to fluoxetine protein 6-like, transcript variant X2
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like isoform X1
nose resistant to fluoxetine protein 6-like isoform X2
myotubularin-related protein 2, transcript variant X1
myotubularin-related protein 2, transcript variant X2
myotubularin-related protein 2, transcript variant X4
myotubularin-related protein 2, transcript variant X6
myotubularin-related protein 2, transcript variant X3
myotubularin-related protein 2, transcript variant X5
myotubularin-related protein 2 isoform X4
myotubularin-related protein 2 isoform X2
myotubularin-related protein 2 isoform X1
myotubularin-related protein 2 isoform X3
putative uncharacterized protein DDB_G0267716, transcript variant X2
putative uncharacterized protein DDB_G0267716, transcript variant X1
putative uncharacterized protein DDB_G0267716 isoform X2
uncharacterized protein LOC122633368 isoform X1
raf homolog serine/threonine-protein kinase Raf
deoxynucleotidyltransferase terminal-interacting protein 2
O-acyltransferase like protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
O-acyltransferase like protein-like, transcript variant X1
O-acyltransferase like protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
O-acyltransferase like protein-like, transcript variant X4
O-acyltransferase like protein-like isoform X2
O-acyltransferase like protein-like isoform X1
O-acyltransferase like protein-like isoform X3
O-acyltransferase like protein-like isoform X4
uncharacterized LOC122633373, transcript variant X2
uncharacterized LOC122633373, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 5, transcript variant X1
26S proteasome non-ATPase regulatory subunit 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 5, transcript variant X2
26S proteasome non-ATPase regulatory subunit 5
uncharacterized LOC122633525, transcript variant X2
uncharacterized LOC122633525, transcript variant X1
uncharacterized protein LOC122633525 isoform X2
uncharacterized protein LOC122633525 isoform X1
putative inorganic phosphate cotransporter, transcript variant X3
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter isoform X3
putative inorganic phosphate cotransporter isoform X2
putative inorganic phosphate cotransporter isoform X1
glutamate receptor ionotropic, delta-1-like, transcript variant X1
glutamate receptor ionotropic, delta-1-like isoform X1
glutamate receptor ionotropic, delta-1-like, transcript variant X2
glutamate receptor ionotropic, delta-1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BMP-binding endothelial regulator protein, transcript variant X1
BMP-binding endothelial regulator protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
BMP-binding endothelial regulator protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
BMP-binding endothelial regulator protein
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, transcript variant X2
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, transcript variant X1
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X1
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X2
RNA pseudouridylate synthase domain-containing protein 2-like isoform X1
RNA pseudouridylate synthase domain-containing protein 2-like isoform X2
protein nessun dorma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
protein nessun dorma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ADP-ribosylation factor-like protein 2-binding protein
ubiquitin carboxyl-terminal hydrolase CYLD
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial
reticulocyte-binding protein PFD0110w-like
ELKS/Rab6-interacting/CAST family member 1-like
COA8 family protein CG14806, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COA8 family protein CG14806, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
COA8 family protein CG14806, mitochondrial isoform X2
COA8 family protein CG14806, mitochondrial isoform X1
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X5
transcription elongation regulator 1, transcript variant X6
transcription elongation regulator 1, transcript variant X7
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X5
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1, transcript variant X8
transcription elongation regulator 1, transcript variant X9
transcription elongation regulator 1 isoform X6
DENN domain-containing protein 10-like, transcript variant X4
DENN domain-containing protein 10-like, transcript variant X3
DENN domain-containing protein 10-like, transcript variant X5
DENN domain-containing protein 10-like, transcript variant X2
DENN domain-containing protein 10-like, transcript variant X1
probable serine/threonine-protein kinase clkA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122633310, transcript variant X3
uncharacterized LOC122633310, transcript variant X1
uncharacterized LOC122633310, transcript variant X2
GATA-binding factor C-like, transcript variant X3
GATA-binding factor C-like, transcript variant X2
GATA-binding factor C-like, transcript variant X1
endothelial transcription factor GATA-2-like isoform X3
uncharacterized LOC122633397, transcript variant X2
uncharacterized LOC122633397, transcript variant X1
lateral signaling target protein 2 homolog
CDK5 regulatory subunit-associated protein 3, transcript variant X2
CDK5 regulatory subunit-associated protein 3, transcript variant X1
CDK5 regulatory subunit-associated protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122633396
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
arginine-hydroxylase NDUFAF5, mitochondrial
ubiquitin-fold modifier-conjugating enzyme 1
mesencephalic astrocyte-derived neurotrophic factor homolog
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
ATP synthase subunit g, mitochondrial, transcript variant X2
ATP synthase subunit g, mitochondrial, transcript variant X1
uncharacterized LOC122633480, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122633480, transcript variant X1
uncharacterized protein LOC122633480 isoform X2
uncharacterized protein LOC122633480 isoform X1
probable tRNA(His) guanylyltransferase, transcript variant X1
probable tRNA(His) guanylyltransferase, transcript variant X2
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X2
WD repeat-containing protein 26, transcript variant X1
WD repeat-containing protein 26, transcript variant X2
WD repeat-containing protein 26 isoform X1
WD repeat-containing protein 26 isoform X2
putative sodium-dependent multivitamin transporter, transcript variant X1
putative sodium-dependent multivitamin transporter, transcript variant X2
putative sodium-dependent multivitamin transporter
galactose mutarotase, transcript variant X5
galactose mutarotase, transcript variant X1
galactose mutarotase, transcript variant X3
galactose mutarotase, transcript variant X2
galactose mutarotase, transcript variant X4
galactose mutarotase, transcript variant X6
choline/ethanolamine kinase, transcript variant X1
choline/ethanolamine kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
choline/ethanolamine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
choline/ethanolamine kinase, transcript variant X3
choline/ethanolamine kinase, transcript variant X2
microtubule-associated protein RP/EB family member 1-like, transcript variant X1
probable serine/threonine-protein kinase kinX isoform X1
microtubule-associated protein RP/EB family member 1-like, transcript variant X2
microtubule-associated protein RP/EB family member 1-like isoform X2
glycine-rich cell wall structural protein-like
palmitoyltransferase app, transcript variant X2
palmitoyltransferase app, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
palmitoyltransferase ZDHHC18-A isoform X1
zinc finger protein 615, transcript variant X2
zinc finger protein 615, transcript variant X1
zinc finger protein 615, transcript variant X3
protein painting of fourth, transcript variant X1
protein painting of fourth, transcript variant X2
probable medium-chain specific acyl-CoA dehydrogenase, mitochondrial
probable serine/threonine-protein kinase yakA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nuclear hormone receptor FTZ-F1, transcript variant X1
nuclear hormone receptor FTZ-F1, transcript variant X2
eukaryotic translation initiation factor 4H-like, transcript variant X1
eukaryotic translation initiation factor 4H-like, transcript variant X3
eukaryotic translation initiation factor 4H-like isoform X1
eukaryotic translation initiation factor 4H-like isoform X3
eukaryotic translation initiation factor 4H-like, transcript variant X2
eukaryotic translation initiation factor 4H-like isoform X2
PHD finger-like domain-containing protein 5A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00291
TRPL translocation defect protein 14, transcript variant X5
TRPL translocation defect protein 14, transcript variant X8
TRPL translocation defect protein 14, transcript variant X6
TRPL translocation defect protein 14 isoform X6
TRPL translocation defect protein 14 isoform X5
TRPL translocation defect protein 14 isoform X8
TRPL translocation defect protein 14, transcript variant X1
TRPL translocation defect protein 14, transcript variant X2
TRPL translocation defect protein 14, transcript variant X3
TRPL translocation defect protein 14, transcript variant X4
TRPL translocation defect protein 14, transcript variant X7
TRPL translocation defect protein 14 isoform X4
TRPL translocation defect protein 14 isoform X2
TRPL translocation defect protein 14 isoform X3
TRPL translocation defect protein 14 isoform X1
TRPL translocation defect protein 14 isoform X7
kelch domain-containing protein 10 homolog
TNF receptor-associated factor 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TNF receptor-associated factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TNF receptor-associated factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TNF receptor-associated factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
TNF receptor-associated factor 4 isoform X1
TNF receptor-associated factor 4 isoform X2
probable DNA replication complex GINS protein PSF2
adenosine receptor A2b-like, transcript variant X2
adenosine receptor A2b-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
5-hydroxytryptamine receptor 1D-like isoform X1
sphingomyelin phosphodiesterase 4, transcript variant X4
sphingomyelin phosphodiesterase 4, transcript variant X1
sphingomyelin phosphodiesterase 4, transcript variant X3
sphingomyelin phosphodiesterase 4, transcript variant X5
sphingomyelin phosphodiesterase 4, transcript variant X2
sphingomyelin phosphodiesterase 4 isoform X4
sphingomyelin phosphodiesterase 4 isoform X1
sphingomyelin phosphodiesterase 4 isoform X3
sphingomyelin phosphodiesterase 4 isoform X5
sphingomyelin phosphodiesterase 4 isoform X2
solute carrier family 23 member 1, transcript variant X2
solute carrier family 23 member 1, transcript variant X1
solute carrier family 23 member 1 isoform X1
solute carrier family 23 member 1 isoform X2
nuclear cap-binding protein subunit 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like
uncharacterized LOC122633511, transcript variant X2
uncharacterized LOC122633511, transcript variant X1
low density lipoprotein receptor adapter protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
low density lipoprotein receptor adapter protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
low density lipoprotein receptor adapter protein 1-like isoform X2
low density lipoprotein receptor adapter protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 43 homolog, transcript variant X3
transmembrane protein 43 homolog, transcript variant X1
transmembrane protein 43 homolog, transcript variant X2
transmembrane protein 43 homolog isoform X1
transmembrane protein 43 homolog isoform X2
transmembrane protein 43 homolog isoform X3
thiamine transporter 1-like, transcript variant X4
thiamine transporter 1-like, transcript variant X1
thiamine transporter 1-like, transcript variant X2
thiamine transporter 1-like, transcript variant X3
serine protease inhibitor 88Ea-like, transcript variant X4
serine protease inhibitor 88Ea-like, transcript variant X2
serine protease inhibitor 88Ea-like isoform X2
serine protease inhibitor 88Ea-like, transcript variant X3
serine protease inhibitor 88Ea-like, transcript variant X1
serine protease inhibitor 88Ea-like, transcript variant X6
serine protease inhibitor 88Ea-like isoform X1
serine protease inhibitor 88Ea-like, transcript variant X5
serine protease inhibitor 88Ea-like isoform X3
mitochondrial import inner membrane translocase subunit Tim22
D-glucuronyl C5-epimerase B, transcript variant X2
D-glucuronyl C5-epimerase B, transcript variant X1
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, transcript variant X2
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, transcript variant X3
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, transcript variant X1
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
protein phosphatase 1 regulatory subunit 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7-like isoform X2
protein phosphatase 1 regulatory subunit 7-like isoform X1
zinc finger CCCH domain-containing protein 13-like
SET domain-containing protein SmydA-8-like
protein eyes shut, transcript variant X1
protein eyes shut, transcript variant X3
protein eyes shut, transcript variant X2
protein eyes shut, transcript variant X5
protein eyes shut, transcript variant X4
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X2
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X1
ATP synthase mitochondrial F1 complex assembly factor 2
thioredoxin reductase-like selenoprotein T homolog CG3887
zinc finger protein 271-like, transcript variant X1
zinc finger protein 271-like, transcript variant X2
zinc finger protein 271-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein abnormal spindle, transcript variant X1
protein abnormal spindle, transcript variant X2
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X4
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X3
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X1
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X6
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X2
TP53-regulated inhibitor of apoptosis 1-like isoform X1
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X5
TP53-regulated inhibitor of apoptosis 1-like isoform X2
FACT complex subunit Ssrp1, transcript variant X1
FACT complex subunit Ssrp1, transcript variant X3
FACT complex subunit Ssrp1, transcript variant X2
cyclic AMP-dependent transcription factor ATF-6 alpha, transcript variant X2
cyclic AMP-dependent transcription factor ATF-6 alpha, transcript variant X1
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X1
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
protein SMG7-like, transcript variant X1
protein SMG7-like, transcript variant X5
protein SMG7-like, transcript variant X4
protein SMG7-like, transcript variant X3
protein SMG7-like, transcript variant X2
transcription factor A, mitochondrial, transcript variant X1
transcription factor A, mitochondrial, transcript variant X2
transcription factor A, mitochondrial isoform X1
transcription factor A, mitochondrial isoform X2
CCR4-NOT transcription complex subunit 3
probable ATP-dependent RNA helicase DDX47, transcript variant X5
probable ATP-dependent RNA helicase DDX47, transcript variant X4
probable ATP-dependent RNA helicase DDX47, transcript variant X2
probable ATP-dependent RNA helicase DDX47, transcript variant X1
probable ATP-dependent RNA helicase DDX47 isoform X2
probable ATP-dependent RNA helicase DDX47 isoform X1
probable ATP-dependent RNA helicase DDX47, transcript variant X3
probable ATP-dependent RNA helicase DDX47 isoform X3
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X4
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X2
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X3
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X6
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X1
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X7
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X5
leucine-rich repeat and death domain-containing protein 1-like isoform X4
leucine-rich repeat and death domain-containing protein 1-like isoform X3
leucine-rich repeat and death domain-containing protein 1-like isoform X2
leucine-rich repeat and death domain-containing protein 1-like isoform X1
corrinoid adenosyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
corrinoid adenosyltransferase-like, transcript variant X1
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like, transcript variant X4
flocculation protein FLO11-like isoform X2
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like isoform X1
flocculation protein FLO11-like, transcript variant X3
flocculation protein FLO11-like isoform X3
flocculation protein FLO11-like isoform X4
flocculation protein FLO11-like, transcript variant X5
flocculation protein FLO11-like isoform X5
flocculation protein FLO11-like, transcript variant X7
flocculation protein FLO11-like, transcript variant X6
flocculation protein FLO11-like isoform X6
flocculation protein FLO11-like isoform X7
lissencephaly-1 homolog A-like, transcript variant X2
lissencephaly-1 homolog A-like, transcript variant X1
lissencephaly-1 homolog A-like isoform X2
uncharacterized protein LOC122633550 isoform X1
DNA topoisomerase 2-binding protein 1, transcript variant X1
DNA topoisomerase 2-binding protein 1, transcript variant X3
DNA topoisomerase 2-binding protein 1, transcript variant X2
DNA topoisomerase 2-binding protein 1 isoform X1
DNA topoisomerase 2-binding protein 1-A isoform X2
maternal embryonic leucine zipper kinase, transcript variant X1
maternal embryonic leucine zipper kinase, transcript variant X6
maternal embryonic leucine zipper kinase, transcript variant X3
maternal embryonic leucine zipper kinase, transcript variant X2
maternal embryonic leucine zipper kinase, transcript variant X5
maternal embryonic leucine zipper kinase, transcript variant X4
serine/threonine-protein kinase ppk16 isoform X1
maternal embryonic leucine zipper kinase isoform X2
choline transporter-like protein 1, transcript variant X3
choline transporter-like protein 1, transcript variant X1
choline transporter-like protein 1, transcript variant X2
choline transporter-like protein 1 isoform X3
choline transporter-like protein 1 isoform X1
choline transporter-like protein 1 isoform X2
probable Na(+)/H(+) antiporter nhx-9, transcript variant X1
probable Na(+)/H(+) antiporter nhx-9, transcript variant X2
probable Na(+)/H(+) antiporter nhx-9 isoform X1
probable Na(+)/H(+) antiporter nhx-9 isoform X2
uridine-cytidine kinase-like 1, transcript variant X1
uridine-cytidine kinase-like 1, transcript variant X2
uridine-cytidine kinase-like 1, transcript variant X3
uridine-cytidine kinase-like 1 isoform X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X3
protein lifeguard 1, transcript variant X2
protein lifeguard 1, transcript variant X1
U3 small nucleolar RNA-associated protein 4 homolog
uncharacterized protein C20orf85 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122633410, transcript variant X3
uncharacterized LOC122633410, transcript variant X4
uncharacterized LOC122633410, transcript variant X1
uncharacterized LOC122633410, transcript variant X2
uncharacterized LOC122633411, transcript variant X2
uncharacterized LOC122633411, transcript variant X1
uncharacterized LOC122633408, transcript variant X2
uncharacterized protein LOC122633408 isoform X2
uncharacterized LOC122633408, transcript variant X1
uncharacterized LOC122633408, transcript variant X3
uncharacterized protein LOC122633408 isoform X1
uncharacterized protein LOC122633408 isoform X3
tyrosine-protein kinase Src64B, transcript variant X1
tyrosine-protein kinase Src64B, transcript variant X2
tyrosine-protein kinase Src64B isoform X2
tyrosine-protein kinase Src64B isoform X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 2
cytochrome c1, heme protein, mitochondrial
protein LSM14 homolog A, transcript variant X1
protein LSM14 homolog A, transcript variant X2
zinc finger protein 511, transcript variant X1
zinc finger protein 511, transcript variant X2
cell death specification protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell death specification protein 2-like isoform X1
cell death specification protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC122633256 isoform X2
40S ribosomal protein S12, mitochondrial, transcript variant X3
40S ribosomal protein S12, mitochondrial, transcript variant X2
40S ribosomal protein S12, mitochondrial, transcript variant X1
40S ribosomal protein S12, mitochondrial isoform X3
40S ribosomal protein S12, mitochondrial isoform X2
40S ribosomal protein S12, mitochondrial isoform X1
keratin-associated protein 19-2-like, transcript variant X1
keratin-associated protein 19-2-like, transcript variant X2
uncharacterized protein LOC122633471 isoform X1
keratin-associated protein 19-2-like isoform X2
mitochondrial genome maintenance exonuclease 1-like
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I, transcript variant X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I, transcript variant X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I
uncharacterized LOC122633463, transcript variant X4
uncharacterized LOC122633463, transcript variant X1
uncharacterized LOC122633463, transcript variant X2
uncharacterized LOC122633463, transcript variant X5
uncharacterized LOC122633463, transcript variant X3
uncharacterized protein LOC122633463 isoform X1
uncharacterized protein LOC122633463 isoform X2
uncharacterized LOC122633463, transcript variant X6
uncharacterized protein LOC122633463 isoform X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like